Management of Inflammatory Bowel Disease-Associated Dysplasia in the Modern Era.

Shah SC, Itzkowitz SH
Gastrointest Endosc Clin N Am. 2019 29 (3): 531-548

PMID: 31078251 · PMCID: PMC7354094 · DOI:10.1016/j.giec.2019.02.008

This article begins with a brief overview of risk factors for colorectal neoplasia in inflammatory bowel disease to concretize the approach to risk stratification. It then provides an up-to-date review of diagnosis and management of dysplasia in inflammatory bowel disease, which integrates new and emerging data in the field. This is particularly relevant in an era of increased attention to cost- and resource-containment from the health systems vantage point, coupled with a heightened prioritization of patient quality of life and shared decision-making. Also provided is a brief discussion of the status of newer therapeutic techniques, such as endoscopic submucosal dissection.

Copyright © 2019 Elsevier Inc. All rights reserved.

MeSH Terms (9)

Colorectal Neoplasms Disease Management Humans Hyperplasia Inflammatory Bowel Diseases Intestines Precancerous Conditions Quality of Life Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: